241 related articles for article (PubMed ID: 1414829)
41. [Contribution of MRI in 5 cases of central diabetes insipidus].
Christophe C; Balériaux D; Hanquinet S; Heinrichs C; Sariban E; Segebarth C; Van Vliet G; Perlmutter N
Pediatrie; 1990; 45(7-8):505-10. PubMed ID: 2170928
[TBL] [Abstract][Full Text] [Related]
42. Brain MR in patients with Langerhans cell histiocytosis: findings and enhancement with Gd-DTPA.
Rosenfield NS; Abrahams J; Komp D
Pediatr Radiol; 1990; 20(6):433-6. PubMed ID: 2392358
[TBL] [Abstract][Full Text] [Related]
43. [Histiocytosis X: clinical observation of 33 cases with special reference to occurrence of hypothalamic-pituitary dysfunction (author's transl)].
Bessho F; Fujiu M; Kinumaki H; Takeuchi H; Yokota S; Ohzeki T; Mizutani S; Kobayashi N
Rinsho Ketsueki; 1979 Nov; 20(11):1420-8. PubMed ID: 317115
[No Abstract] [Full Text] [Related]
44. Endocrine changes in histiocytosis of the hypothalamic-pituitary axis.
Toro Galván S; Planas Vilaseca A; Michalopoulou Alevras T; Torres Díaz A; Suárez Balaguer J; Villabona Artero C
Endocrinol Nutr; 2015 Feb; 62(2):72-9. PubMed ID: 25434508
[TBL] [Abstract][Full Text] [Related]
45. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
[TBL] [Abstract][Full Text] [Related]
46. [Magnetic resonance imaging in central diabetes insipidus in children and adolescents. findings at diagnosis and during follow-up].
Alonso G; Bergadá I; Heinrich JJ
An Esp Pediatr; 2000 Aug; 53(2):100-5. PubMed ID: 11083950
[TBL] [Abstract][Full Text] [Related]
47. [On the substrate of transitory diabetes insipidus in the Hand-Schüller-Christian syndrome].
Müller D
Acta Neuroveg (Wien); 1967; 30(1):303-13. PubMed ID: 6080689
[No Abstract] [Full Text] [Related]
48. Clinical characteristics of central diabetes insipidus in Taiwanese children.
Liu SY; Tung YC; Lee CT; Liu HM; Peng SF; Wu MZ; Kuo MF; Tsai WY
J Formos Med Assoc; 2013 Oct; 112(10):616-20. PubMed ID: 23916565
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathological features and BRAF
Huo Z; Lu T; Liang Z; Ping F; Shen J; Lu J; Ma W; Zhao D; Zhong D
Diagn Pathol; 2016 Oct; 11(1):100. PubMed ID: 27760550
[TBL] [Abstract][Full Text] [Related]
50. Hypothalamic-pituitary vascularization in pituitary stalk transection syndrome: is the pituitary stalk really transected? The role of gadolinium-DTPA with spin-echo T1 imaging and turbo-FLASH technique.
Genovese E; Maghnie M; Beluffi G; Villa A; Sammarchi L; Severi F; Campani R
Pediatr Radiol; 1997 Jan; 27(1):48-53. PubMed ID: 8995168
[TBL] [Abstract][Full Text] [Related]
51. Management of diabetes insipidus and adipsia in the child.
Di Iorgi N; Morana G; Napoli F; Allegri AE; Rossi A; Maghnie M
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):415-36. PubMed ID: 26051300
[TBL] [Abstract][Full Text] [Related]
52. Spontaneous regression of isolated neurohypophyseal langerhans cell histiocytosis with diabetes insipidus.
Nagasaki K; Tsumanuma I; Yoneoka Y; Ogawa Y; Kikuchi T; Uchiyama M
Endocr J; 2009; 56(5):721-5. PubMed ID: 19461161
[TBL] [Abstract][Full Text] [Related]
53. Primary hypothyroidism, precocious puberty and hypothalamic obesity in Langerhans cell histiocytosis.
Priyambada L; Bhatia V; Krishnani N; Agarwal V; Bhattacharyya A; Jain S; Mishra SK; Marwaha RK
Indian J Pediatr; 2011 Mar; 78(3):351-3. PubMed ID: 21038089
[TBL] [Abstract][Full Text] [Related]
54. Hypercalcemia in isolated hypothalamic-pituitary Langerhans cell histiocytosis with no bone lesions.
Zornitzki T; Schattner A; Knobler H
Am J Med; 2004 Oct; 117(7):533-4. PubMed ID: 15464715
[No Abstract] [Full Text] [Related]
55. Endocrine Outcomes In Central Diabetes Insipidus: the Predictive Value of Neuroimaging "Mismatch Pattern".
Bianco D; Napoli F; Morana G; Pistorio A; Allegri AEM; Fava D; Schiavone M; Thiabat HF; Crocco M; Camia T; Lezzi M; Calandrino A; Tortora D; Severino M; Patti G; Ibba A; Rossi A; Di Iorgi N; Maghnie M
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32797230
[TBL] [Abstract][Full Text] [Related]
56. Timing of pituitary stalk assessment in Langerhans cell histiocytosis: "when" is sometimes more important than "what".
Maghnie M; Malattia C
J Clin Endocrinol Metab; 2004 Aug; 89(8):4166; author reply 4166-7. PubMed ID: 15292366
[No Abstract] [Full Text] [Related]
57. Diabetes insipidus.
Maghnie M
Horm Res; 2003; 59 Suppl 1():42-54. PubMed ID: 12566720
[TBL] [Abstract][Full Text] [Related]
58. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.
Ottaviano F; Finlay JL
J Pediatr Hematol Oncol; 2003 Jul; 25(7):575-7. PubMed ID: 12847329
[TBL] [Abstract][Full Text] [Related]
59. Demonstration of CD1a positive cells in the cerebrospinal fluid--A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic-pituitary axis?
Prosch H; Feldges A; Grois N; Fretz C; Spieler P; Minkov M; Gadner H
Med Pediatr Oncol; 2003 Nov; 41(5):474-6. PubMed ID: 14515394
[No Abstract] [Full Text] [Related]
60. Diabetes insipidus for five years preceding the diagnosis of hypothalamic Langerhans cell histiocytosis.
Catalina PF; Rodr'iguez Garc'ia M; de la Torre C; P'aramo C; Garc'ia-Mayor RV
J Endocrinol Invest; 1995 Sep; 18(8):663-6. PubMed ID: 8655927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
